Space background
_Company

Decision-grade data from space biology.

... enabling pharma and biotech companies to discover, validate, and translate gravity-sensitive biological and formulation effects into decision-grade data.

ResearchSat is leveraging the space microgravity to drive advancements in medical and life sciences. Through unwavering commitment and effort, the team is steadily moving closer to their vision of a healthier global community.

What we are building

From today's research services to tomorrow's orbital manufacturing infrastructure.

2020
2022
2024
2026
2028
2030
01
Foundation
Company Founded & R&D
Active
ResearchSat founded. R&D, payload design, and mission architecture established.
02
Research
First Mission Launch
Active
Inaugural atmospheric and suborbital missions — UDAAN yeast experiment and ADI-Alpha payload launch.
03
Validation
Follow-up Launches
Active
Continued suborbital and orbital campaign launches — expanding payload capability and biological data sets.
04
Orbital
3rd Mission Launch (LEO)
In development
Third mission — LEO orbital launch currently in progress, advancing continuous microgravity research access.
05
ISS
ISS Mission
Roadmap
Scheduled ISS mission — astronaut-assisted experiments for pioneering life-science and biomaterials research.
06
Bioreactor
Space Bioreactor Launch
Roadmap
Bioreactor platform in development — planned 2028 launch for in-orbit cell cultivation and CMC bioprocessing.
07
Commercial
Commercial Space Biologics
Future
End-to-end commercial orbital biomanufacturing for pharma-grade biologics and advanced materials at scale.
Now

Meet the Team

Meet the core operators and advisors building ResearchSat's microgravity platform for life-science and formulation development.

_Why ResearchSat

A space CRO built around your science question.

01

Ground-first screening

Only the best hypotheses reach orbit.

We validate candidates in simulated microgravity before committing to flight hardware. Only the hypotheses most likely to produce signal reach orbit.

MagRise magnetic levitation screening de-risks biological and formulation candidates terrestrially — reducing wasted flight slots and giving sponsors statistically powered go/no-go decisions before any payload is built.

MagRise simulationGo/No-Go dataCost reduction
Ground-first screening
Research partners & collaborators
Partner 1
Partner 2
Partner 3
Partner 4
Partner 5
Partner 6
Partner 7
Partner 8
Partner 9
Partner 10
Partner 11
Partner 12
Partner 13
Partner 14
Partner 15
Partner 16
Partner 1
Partner 2
Partner 3
Partner 4
Partner 5
Partner 6
Partner 7
Partner 8
Partner 9
Partner 10
Partner 11
Partner 12
Partner 13
Partner 14
Partner 15
Partner 16
_News

Here's what's new with us

View All
ResearchSat Team

ResearchSat Team

ResearchSat is translating microgravity biology and formulation effects into controlled studies, platform data, and sponsor-ready evidence packages...

Read More
Partnership

Expanded TWBIO Partnership for Space Habitat Technology

15 Sep 2025
Partnership

HelioX Cosmos Strategic Partnership for Cislunar Missions

08 Sep 2025
Technology

Microfluidic Technology Partnership with Anntong Company

01 Sep 2025
Recognition

ResearchSat Selected for TACC+ Taiwan International SpaceTech Program

23 Jun 2025
Media

Lot Fourteen Feature on Microgravity Breakthroughs

21 Apr 2025
Recognition

Industry Recognition – Start‑ups to Watch 2025

Apr 2025
Partnership

Cryogenics Alliance: ResearchSat × Onnes Cryogenics

26 Mar 2025
Research

LinkedIn Knowledge Series – Regenerative Medicine in Space

19 Mar 2025
Article

Editorial: Space Bioreactors as Catalysts for Discovery

08 Mar 2025

From question
to orbit.

Bring us the molecule, formulation, cell system, or assay question where gravity may matter.

We scope the experiment, build the payload, manage the mission, and deliver a decision-ready dataset — so your team focuses on the science, not the logistics.

Free discovery call — no commitment required. We scope the experiment, send you a written proposal, and you decide.